Table 2.

Linear Regression Between Number of Dental Abscess/Month and Treatment Received (Burosumab or Conventional Treatment)

Variables	Beta coefficient	Univariate p value	Multivariate p value
Sex (female)	−0.04	0.0001	0.0002
Type of XLH treatment (burosumab)	−0.02	0.02	0.12
Age at XLH treatment onset	−0.0002	0.02	0.47
Dental follow‐up duration	−0.0003	0.09
Age at dental follow‐up onset	−0.0002	0.15
Alkaline phosphatase level	0.0004	0.3
Dental caries during dental follow‐up	−0.009	0.49
XLH treatment duration	0.0001	0.87